Experimental and Clinical Research Center (ECRC), Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; Pharmaimage Biomarker Solutions GmbH, Berlin, Germany.
Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg, Luxembourg.
Eur Psychiatry. 2018 Apr;50:34-39. doi: 10.1016/j.eurpsy.2017.10.004. Epub 2018 Feb 3.
Postoperative cognitive impairment is among the most common medical complications associated with surgical interventions - particularly in elderly patients. In our aging society, it is an urgent medical need to determine preoperative individual risk prediction to allow more accurate cost-benefit decisions prior to elective surgeries. So far, risk prediction is mainly based on clinical parameters. However, these parameters only give a rough estimate of the individual risk. At present, there are no molecular or neuroimaging biomarkers available to improve risk prediction and little is known about the etiology and pathophysiology of this clinical condition. In this short review, we summarize the current state of knowledge and briefly present the recently started BioCog project (Biomarker Development for Postoperative Cognitive Impairment in the Elderly), which is funded by the European Union. It is the goal of this research and development (R&D) project, which involves academic and industry partners throughout Europe, to deliver a multivariate algorithm based on clinical assessments as well as molecular and neuroimaging biomarkers to overcome the currently unsatisfying situation.
术后认知障碍是与手术干预相关的最常见的医学并发症之一,尤其是在老年患者中。在我们这个老龄化的社会中,确定术前个体风险预测以在选择性手术前做出更准确的成本效益决策是当务之急。到目前为止,风险预测主要基于临床参数。然而,这些参数只能粗略估计个体风险。目前,还没有分子或神经影像学生物标志物可用于改善风险预测,对于这种临床情况的病因和病理生理学知之甚少。在这篇简短的综述中,我们总结了目前的知识状况,并简要介绍了最近启动的 BioCog 项目(老年人术后认知障碍的生物标志物开发),该项目由欧盟资助。这个涉及欧洲各地学术和行业合作伙伴的研发项目的目标是提供一种基于临床评估以及分子和神经影像学生物标志物的多元算法,以克服目前令人不满意的情况。